Cardiff Lexington Upgrades to OTCQX Market
Analysis based on 8 articles · First reported Apr 09, 2026 · Last updated Apr 09, 2026
The upgrade of Cardiff Lexington Corporation to the OTCQX Best Market is expected to increase its visibility and attract a broader base of U.S. investors, potentially leading to enhanced shareholder value and improved access to capital. This move also highlights the importance of platforms like OTCQX Best Market in providing transparent and regulated trading environments for growing companies.
Cardiff Lexington Corporation, a publicly traded healthcare services holding company, has qualified to trade on the OTCQX Best Market, upgrading from the OTCQB Venture Market. This move, effective April 9, 2026, is seen as a significant milestone by CEO Alex Cunningham, aiming to enhance the company's visibility among U.S. investors and pave the way for a future listing on a major U.S. exchange like NYSE American or Nasdaq Capital Market. The company has demonstrated consistent financial growth, with revenue increasing by 39.5% in 2025, and focuses on a three-pillar growth strategy involving core cash flow platforms, asset acquisition, and a finance strategy. The upgrade reflects Cardiff Lexington Corporation's commitment to high financial standards and corporate governance, which is crucial for its strategy of expanding working capital and scaling operations, particularly through its subsidiary Cardiff Lexington Corporation===Nova Ortho and Spine.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard